Gosall

Gosall is an oral formulation that contains the second‑generation antihistamine bilastine. It is marketed in the European Union and is classified as a selective peripheral H1‑receptor antagonist. The product is intended for the relief of allergic symptoms and is supplied without a specified strength or dosage form in this description.

Gosall is indicated for the management of allergic conditions that involve histamine release. It is commonly prescribed for the following clinical situations:

- Seasonal or perennial allergic rhinitis - Chronic idiopathic urticaria (hives) - Allergic conjunctivitis associated with rhinitis - Relief of itching, sneezing, and nasal congestion caused by allergens - Adjunct therapy for other histamine‑mediated skin reactions

Side effects of bilastine are generally mild, but patients should be aware of both common and less frequent reactions.

Common: - Headache - Dry mouth - Fatigue or drowsiness (rare for second‑generation antihistamines) - Nausea - Dizziness

Serious: - Severe skin rash or Stevens‑Johnson syndrome - Anaphylactic reactions such as swelling of the face, lips, or throat - Cardiac arrhythmias (very rare) - Persistent tachycardia

Before using Gosall, consider the following safety points:

- Assess renal or hepatic impairment, as dose adjustment may be required. - Use caution in pregnant or breastfeeding individuals; consult a healthcare professional. - Avoid driving or operating machinery if you experience dizziness. - Monitor for signs of allergic reactions despite the antihistamine effect. - Review all concomitant medications for potential interactions. - Discontinue use and seek medical advice if serious skin reactions develop.

Bilastine may interact with several drug classes. Understanding which combinations to avoid or use cautiously can help maintain safety.

Avoid: - Antifungal agents such as ketoconazole and itraconazole, which can increase bilastine plasma levels. - Certain macrolide antibiotics (e.g., erythromycin) that affect P‑glycoprotein transport. - Strong CYP3A4 inhibitors, although bilastine is not primarily metabolized by CYP enzymes, they may still affect absorption.

Use with caution: - Alcohol, which can enhance sedation. - Other antihistamines or sedating medications, potentially increasing drowsiness. - Food high in fat, as it may reduce bilastine absorption. - Medications that prolong the QT interval, especially in patients with cardiac risk factors.